FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake

Fibroblast growth factor 21 (FGF21) is an endocrine hormone produced by the liver that regulates nutrient and metabolic homeostasis. FGF21 production is increased in response to macronutrient imbalance and signals to the brain to suppress sugar intake and sweet-taste preference. However, the central...

Full description

Saved in:

Bibliographic Details
Published in:	Cell metabolism Vol. 32; no. 2; p. 273
Main Authors:	Jensen-Cody, Sharon O, Flippo, Kyle H, Claflin, Kristin E, Yavuz, Yavuz, Sapouckey, Sarah A, Walters, Grant C, Usachev, Yuriy M, Atasoy, Deniz, Gillum, Matthew P, Potthoff, Matthew J
Format:	Journal Article
Language:	English
Published:	United States 04.08.2020
Subjects:	VMH liver hepatokine PVN sugar intake sweet-taste preference brain macronutrient glucose sensing hypothalamus FGF21
ISSN:	1932-7420, 1932-7420
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Fibroblast growth factor 21 (FGF21) is an endocrine hormone produced by the liver that regulates nutrient and metabolic homeostasis. FGF21 production is increased in response to macronutrient imbalance and signals to the brain to suppress sugar intake and sweet-taste preference. However, the central targets mediating these effects have been unclear. Here, we identify FGF21 target cells in the hypothalamus and reveal that FGF21 signaling to glutamatergic neurons is both necessary and sufficient to mediate FGF21-induced sugar suppression and sweet-taste preference. Moreover, we show that FGF21 acts directly in the ventromedial hypothalamus (VMH) to specifically regulate sucrose intake, but not non-nutritive sweet-taste preference, body weight, or energy expenditure. Finally, our data demonstrate that FGF21 affects neuronal activity by increasing activation and excitability of neurons in the VMH. Thus, FGF21 signaling to glutamatergic neurons in the VMH is an important component of the neurocircuitry that functions to regulate sucrose intake.
AbstractList	Fibroblast growth factor 21 (FGF21) is an endocrine hormone produced by the liver that regulates nutrient and metabolic homeostasis. FGF21 production is increased in response to macronutrient imbalance and signals to the brain to suppress sugar intake and sweet-taste preference. However, the central targets mediating these effects have been unclear. Here, we identify FGF21 target cells in the hypothalamus and reveal that FGF21 signaling to glutamatergic neurons is both necessary and sufficient to mediate FGF21-induced sugar suppression and sweet-taste preference. Moreover, we show that FGF21 acts directly in the ventromedial hypothalamus (VMH) to specifically regulate sucrose intake, but not non-nutritive sweet-taste preference, body weight, or energy expenditure. Finally, our data demonstrate that FGF21 affects neuronal activity by increasing activation and excitability of neurons in the VMH. Thus, FGF21 signaling to glutamatergic neurons in the VMH is an important component of the neurocircuitry that functions to regulate sucrose intake. Fibroblast growth factor 21 (FGF21) is an endocrine hormone produced by the liver that regulates nutrient and metabolic homeostasis. FGF21 production is increased in response to macronutrient imbalance and signals to the brain to suppress sugar intake and sweet-taste preference. However, the central targets mediating these effects have been unclear. Here, we identify FGF21 target cells in the hypothalamus and reveal that FGF21 signaling to glutamatergic neurons is both necessary and sufficient to mediate FGF21-induced sugar suppression and sweet-taste preference. Moreover, we show that FGF21 acts directly in the ventromedial hypothalamus (VMH) to specifically regulate sucrose intake, but not non-nutritive sweet-taste preference, body weight, or energy expenditure. Finally, our data demonstrate that FGF21 affects neuronal activity by increasing activation and excitability of neurons in the VMH. Thus, FGF21 signaling to glutamatergic neurons in the VMH is an important component of the neurocircuitry that functions to regulate sucrose intake.Fibroblast growth factor 21 (FGF21) is an endocrine hormone produced by the liver that regulates nutrient and metabolic homeostasis. FGF21 production is increased in response to macronutrient imbalance and signals to the brain to suppress sugar intake and sweet-taste preference. However, the central targets mediating these effects have been unclear. Here, we identify FGF21 target cells in the hypothalamus and reveal that FGF21 signaling to glutamatergic neurons is both necessary and sufficient to mediate FGF21-induced sugar suppression and sweet-taste preference. Moreover, we show that FGF21 acts directly in the ventromedial hypothalamus (VMH) to specifically regulate sucrose intake, but not non-nutritive sweet-taste preference, body weight, or energy expenditure. Finally, our data demonstrate that FGF21 affects neuronal activity by increasing activation and excitability of neurons in the VMH. Thus, FGF21 signaling to glutamatergic neurons in the VMH is an important component of the neurocircuitry that functions to regulate sucrose intake.
Author	Walters, Grant C Usachev, Yuriy M Gillum, Matthew P Atasoy, Deniz Yavuz, Yavuz Flippo, Kyle H Claflin, Kristin E Sapouckey, Sarah A Potthoff, Matthew J Jensen-Cody, Sharon O
Author_xml	– sequence: 1 givenname: Sharon O surname: Jensen-Cody fullname: Jensen-Cody, Sharon O organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 2 givenname: Kyle H surname: Flippo fullname: Flippo, Kyle H organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 3 givenname: Kristin E surname: Claflin fullname: Claflin, Kristin E organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 4 givenname: Yavuz surname: Yavuz fullname: Yavuz, Yavuz organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 5 givenname: Sarah A surname: Sapouckey fullname: Sapouckey, Sarah A organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 6 givenname: Grant C surname: Walters fullname: Walters, Grant C organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 7 givenname: Yuriy M surname: Usachev fullname: Usachev, Yuriy M organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 8 givenname: Deniz surname: Atasoy fullname: Atasoy, Deniz organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA – sequence: 9 givenname: Matthew P surname: Gillum fullname: Gillum, Matthew P email: gillum@sund.ku.dk organization: Section for Nutrient and Metabolite Sensing, the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2200 Copenhagen, Denmark. Electronic address: gillum@sund.ku.dk – sequence: 10 givenname: Matthew J surname: Potthoff fullname: Potthoff, Matthew J email: matthew-potthoff@uiowa.edu organization: Department of Neuroscience and Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Iowa Neuroscience Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA; Department of Veterans Affairs Medical Center, Iowa City, IA 52242, USA. Electronic address: matthew-potthoff@uiowa.edu
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/32640184$$D View this record in MEDLINE/PubMed
BookMark	eNpNkEtPwzAQhC1URGnhD3BAPnJJWD_iNEdU0YdUwaHANXLSTZuS2MF2Dv33RFAkTjtafTOrnQkZGWuQkDsGMQOmHo9x2WKIOXCIQcUAswtyzTLBo1RyGP3TYzLx_ggglMjEFRkLriSwmbwm-8VywRnd1nujG0-DpcumD7rVAd2-LukL9s4aT2tDwwHpB5rgbIu7Wjd0depsOOhGt_2Pc9t3nUPv6Vy7wh5OOzek0LUJ-hNvyGU1HMDb85yS98Xz23wVbV6X6_nTJioTzkKkdMkUTzTwXZpixSosE6bSqsxShRJEhjDLQEihZCJ1BYUqWCoqPiy4yrjkU_Lwm9s5-9WjD3lb-xKbRhu0vc8HhAPImRQDen9G-2L4KO9c3Wp3yv_K4d-AOWif
CitedBy_id	crossref_primary_10_1016_j_molmet_2020_101138 crossref_primary_10_3390_cells10092418 crossref_primary_10_3389_fendo_2020_601290 crossref_primary_10_3390_ijms25147621 crossref_primary_10_1016_j_cmet_2025_04_014 crossref_primary_10_3389_fendo_2023_1095440 crossref_primary_10_3389_fendo_2025_1619462 crossref_primary_10_1016_j_neuropharm_2024_110010 crossref_primary_10_1248_yakushi_24_00177_3 crossref_primary_10_3389_fendo_2021_773975 crossref_primary_10_1152_ajpendo_00138_2025 crossref_primary_10_1016_j_tem_2021_08_008 crossref_primary_10_3390_antiox11081426 crossref_primary_10_1038_s41573_024_01125_w crossref_primary_10_3390_ijms232113045 crossref_primary_10_1002_bmm2_12138 crossref_primary_10_3389_fphys_2021_625287 crossref_primary_10_1016_j_biopha_2023_115737 crossref_primary_10_1007_s11154_021_09661_1 crossref_primary_10_1016_j_neuropharm_2025_110529 crossref_primary_10_3389_fendo_2020_601349 crossref_primary_10_1038_s41380_023_02107_x crossref_primary_10_3390_ijms232113318 crossref_primary_10_1016_j_pharmthera_2025_108844 crossref_primary_10_1146_annurev_nutr_062320_111849 crossref_primary_10_1097_MOL_0000000000000960 crossref_primary_10_1016_j_tem_2024_02_013 crossref_primary_10_3390_ijms221910561 crossref_primary_10_1016_j_cmet_2021_09_010 crossref_primary_10_1111_cns_14302 crossref_primary_10_1038_s41598_020_76593_2 crossref_primary_10_3390_metabo12050460 crossref_primary_10_1016_j_molmet_2024_102049 crossref_primary_10_1146_annurev_nutr_111120_111518 crossref_primary_10_3389_fnut_2021_655833 crossref_primary_10_1016_j_drugalcdep_2023_109809 crossref_primary_10_1016_j_appet_2024_107673 crossref_primary_10_3389_fendo_2022_932761 crossref_primary_10_1016_j_ebiom_2024_105458 crossref_primary_10_4103_cjop_CJOP_D_22_00131 crossref_primary_10_3389_fphar_2022_1011008 crossref_primary_10_1093_procel_pwaf027 crossref_primary_10_1016_j_lfs_2023_121900 crossref_primary_10_1016_j_neuropharm_2021_108744 crossref_primary_10_1073_pnas_2012073117 crossref_primary_10_3389_fendo_2022_900034 crossref_primary_10_1038_s12276_022_00758_4 crossref_primary_10_1002_oby_23432 crossref_primary_10_1016_j_molmet_2022_101564 crossref_primary_10_1016_j_jcmgh_2025_101531 crossref_primary_10_3390_clockssleep3010012 crossref_primary_10_3390_children9060821 crossref_primary_10_3390_nu13114103 crossref_primary_10_1038_s42255_021_00354_2 crossref_primary_10_1515_revneuro_2022_0072 crossref_primary_10_3390_life13020432 crossref_primary_10_4274_haseki_galenos_2023_8387 crossref_primary_10_1146_annurev_cellbio_120420_015303 crossref_primary_10_1038_s41398_025_03425_0 crossref_primary_10_3389_fendo_2022_975509 crossref_primary_10_1016_j_celrep_2024_114403 crossref_primary_10_3389_fnut_2025_1587690 crossref_primary_10_1016_j_lfs_2025_123940 crossref_primary_10_1016_j_molmet_2021_101324 crossref_primary_10_1134_S0022093024020315 crossref_primary_10_3390_jcm11030580 crossref_primary_10_1016_j_neuropharm_2021_108920 crossref_primary_10_1002_wsbm_1549 crossref_primary_10_1098_rsob_250092 crossref_primary_10_1016_j_jhep_2024_04_034 crossref_primary_10_1038_s42255_022_00602_z crossref_primary_10_3390_biomedicines11051427 crossref_primary_10_1016_j_molmet_2023_101718 crossref_primary_10_3390_nu13113954 crossref_primary_10_1016_j_jconrel_2025_113587 crossref_primary_10_1055_a_1778_4159 crossref_primary_10_1016_j_lfs_2022_121015 crossref_primary_10_1016_j_ijbiomac_2024_132667 crossref_primary_10_1016_j_physbeh_2023_114368 crossref_primary_10_1016_j_physbeh_2022_113995 crossref_primary_10_1002_cne_25306 crossref_primary_10_3389_fmolb_2025_1542100 crossref_primary_10_1016_j_cmet_2021_12_024 crossref_primary_10_1093_lifemedi_lnac051 crossref_primary_10_3390_proteomes9030037 crossref_primary_10_1016_j_molmet_2020_101152 crossref_primary_10_1016_j_metabol_2022_155166 crossref_primary_10_3389_fendo_2021_802541 crossref_primary_10_1210_endocr_bqae120 crossref_primary_10_3389_fphar_2022_1089214 crossref_primary_10_3389_fphar_2025_1610498 crossref_primary_10_3389_fcvm_2022_962561 crossref_primary_10_1016_j_ajhg_2021_12_013 crossref_primary_10_1016_j_ejphar_2023_176248 crossref_primary_10_1017_S0007114523001927 crossref_primary_10_1016_j_isci_2022_104315 crossref_primary_10_1038_s41574_020_0396_y crossref_primary_10_4093_dmj_2024_0390 crossref_primary_10_1016_j_jbc_2021_100623
ContentType	Journal Article
Copyright	Published by Elsevier Inc.
Copyright_xml	– notice: Published by Elsevier Inc.
DBID	NPM 7X8
DOI	10.1016/j.cmet.2020.06.008
DatabaseName	PubMed MEDLINE - Academic
DatabaseTitle	PubMed MEDLINE - Academic
DatabaseTitleList	PubMed MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Biology
EISSN	1932-7420
ExternalDocumentID	32640184
Genre	Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NIDDK NIH HHS grantid: R01 DK106104 – fundername: NIGMS NIH HHS grantid: T32 GM067795 – fundername: NIDDK NIH HHS grantid: F31 DK117515 – fundername: NINDS NIH HHS grantid: R01 NS096246 – fundername: BLRD VA grantid: I01 BX004634 – fundername: NIDDK NIH HHS grantid: T32 DK112751 – fundername: NIH HHS grantid: S10 OD016199 – fundername: NIDDK NIH HHS grantid: F32 DK117510 – fundername: NIAAA NIH HHS grantid: R01 AA027654 – fundername: NINDS NIH HHS grantid: R01 NS087068
GroupedDBID	--- --K 0R~ 1~5 29B 2WC 4.4 457 4G. 53G 5GY 62- 6J9 7-5 AAEDT AAEDW AAKRW AAKUH AALRI AAMRU AAVLU AAXUO AAYWO ABDGV ABJNI ABMAC ACGFO ACGFS ACVFH ADBBV ADCNI ADEZE ADVLN AEFWE AENEX AEUPX AEXQZ AFPUW AFTJW AGCQF AGKMS AIGII AITUG AKAPO AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL CS3 DIK DU5 E3Z EBS EFKBS F5P FCP FDB FEDTE FIRID HVGLF IHE IXB J1W JIG M3Z M41 NPM O-L O9- OK1 P2P ROL RPZ SES SSZ TR2 UNMZH 7X8
ID	FETCH-LOGICAL-c521t-6ac1625a02d77ef1fec5167fc976e4039e08903436454af0b6b173f2436269242
IEDL.DBID	7X8
ISICitedReferencesCount	118
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000555971500005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1932-7420
IngestDate	Thu Oct 02 05:49:18 EDT 2025 Mon Jul 21 06:02:45 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	VMH liver hepatokine PVN sugar intake sweet-taste preference brain macronutrient glucose sensing hypothalamus FGF21
Language	English
License	Published by Elsevier Inc.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c521t-6ac1625a02d77ef1fec5167fc976e4039e08903436454af0b6b173f2436269242
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	http://www.cell.com/article/S1550413120303090/pdf
PMID	32640184
PQID	2422004843
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2422004843 pubmed_primary_32640184
PublicationCentury	2000
PublicationDate	2020-08-04
PublicationDateYYYYMMDD	2020-08-04
PublicationDate_xml	– month: 08 year: 2020 text: 2020-08-04 day: 04
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Cell metabolism
PublicationTitleAlternate	Cell Metab
PublicationYear	2020
References	32690916 - Nat Rev Endocrinol. 2020 Sep;16(9):472
References_xml	– reference: 32690916 - Nat Rev Endocrinol. 2020 Sep;16(9):472
SSID	ssj0036393
Score	2.6201906
Snippet	Fibroblast growth factor 21 (FGF21) is an endocrine hormone produced by the liver that regulates nutrient and metabolic homeostasis. FGF21 production is...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	273
Title	FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake
URI	https://www.ncbi.nlm.nih.gov/pubmed/32640184 https://www.proquest.com/docview/2422004843
Volume	32
WOSCitedRecordID	wos000555971500005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qFbz4ftQXEbwGs0n2dRIpbitoKailtyVNsrWIu7XbCv33TrJbPQmCl71lCTPDzDePfIPQFQQJqXwmiAwUJcKPYhILnxPN_cwXOtbSMd70H8JuNxoM4l5dcCvrscqlT3SOWhfK1sivIZRYhUaC30w-iN0aZbur9QqNVdTgAGXsSFc4-O4icIi-vOoqA4oUjNaPZqr5LvVu7Cwlo46_k0a_Q0wXapLt_15yB23VIBPfVlaxi1ZMvoc2qrWTi300StoJ8_DTeGTJk_GswG2wPwnY1UzBEWJH2JGXeJxjgIe4bwvARfXEBHcWE9CtBDuau5N2K6jN2HFLTofF60Jb6gl8n8_kmzlAL8ndc6tD6oULRNm9BiSQyoN8SFKmw9BkXmaU7wVhpgCzGEF5bGgUUy5s61LIjA6DoRfyjAnLaQOJHDtEa3mRm2OEDQWcBWjCcKYEJG0SgAUXBn4TaR0av4kulxJMwaBtl0LmppiX6Y8Mm-ioUkM6qZg3UsCakA9G4uQPp0_RptWuG9YTZ6iRgUTNOVpXn7NxOb1wlgLfbu_xC6t1xiU
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FGF21+Signals+to+Glutamatergic+Neurons+in+the+Ventromedial+Hypothalamus+to+Suppress+Carbohydrate+Intake&rft.jtitle=Cell+metabolism&rft.au=Jensen-Cody%2C+Sharon+O&rft.au=Flippo%2C+Kyle+H&rft.au=Claflin%2C+Kristin+E&rft.au=Yavuz%2C+Yavuz&rft.date=2020-08-04&rft.issn=1932-7420&rft.eissn=1932-7420&rft.volume=32&rft.issue=2&rft.spage=273&rft_id=info:doi/10.1016%2Fj.cmet.2020.06.008&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-7420&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-7420&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-7420&client=summon